Fig. 1
From: A review of Janus kinase inhibitors for the treatment of Covid-19 pneumonia
JAK/STAT signal pathway and its inhibitor. Cytokines and growth factors bind to cell surface receptors and activate the associated JAK-STAT signaling pathway
Fig. 1 | Inflammation and Regeneration